Cargando…
Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Studies have shown that bradykinin (BK) is highly expressed in liver cancer. We designed the novel BK receptor inhibitors J051-71 and J051-105, which reduced the viability of liver cancer cells and inhibited the formation of c...
Autores principales: | Wang, Yiou, Zhang, Bingxue, Huang, Yibing, Yao, Wenjun, Tao, Fei, Chen, Yuxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272207/ https://www.ncbi.nlm.nih.gov/pubmed/34206871 http://dx.doi.org/10.3390/molecules26133915 |
Ejemplares similares
-
Desmocollin-2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma via the ERK/c-MYC signaling pathway
por: He, Bo, et al.
Publicado: (2022) -
Leptin Receptor (LEPR) promotes proliferation, migration, and invasion and inhibits apoptosis in hepatocellular carcinoma by regulating ANXA7
por: Huang, He, et al.
Publicado: (2021) -
Gluconokinase IDNK Promotes Cell Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma
por: Wu, Xiao-Min, et al.
Publicado: (2020) -
Neprilysin Inhibitors and Bradykinin
por: Campbell, Duncan J.
Publicado: (2018) -
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway
por: Xing, Ying, et al.
Publicado: (2021)